About
A registry, not an advocate
A Schedule I drug just passed Phase 3. This site exists to document that properly, because the internet has a thousand sites explaining what these molecules are and almost none answering the question underneath it.
Last updated August 2026
What this is
Every registered clinical trial of LSD, psilocybin, MDMA, DMT, ibogaine and mescaline, plus ketamine where the indication is psychiatric, taken from the US federal registry. Who is running it, what it tests, what counts as success, and where it recruits.
Nothing here is written by a model. Every page carries the NCT number so you can check it against the source.
What it deliberately is not
No sourcing, vendors or marketplace. No dosing guidance for unsupervised use. No AI that counsels anyone through a session. No forum. No claim that any of this works: that is what the trials are for, and most are not finished.
How it makes money
By connecting people with trials looking for participants, and by flat-fee listings for clinics and licensed services. Never by payment per patient sent to a clinic, laboratory or treatment facility, which is both a criminal-law question and the fastest way to make a directory worthless.
The full account is in the editorial policy.
Corrections
If a figure here is wrong, it is either wrong in the registry or wrong in our processing, and we want to know which.